Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the exercise of 35,059,448 warrants, which were...